The Role of Platelet Rich Plasma for Erectile Dysfunction

Last updated: August 25, 2023
Sponsor: University of Nebraska
Overall Status: Terminated

Phase

3

Condition

Erectile Dysfunction

Infertility

Male Hormonal Deficiencies/abnormalities

Treatment

Placebo Sham Injection

Platelet rich plasma

Clinical Study ID

NCT04357353
0156-20-FB
  • Ages 50-80
  • Male
  • Accepts Healthy Volunteers

Study Summary

Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • history of mild to moderate erectile dysfunction measured by IIEF

Exclusion

Exclusion Criteria:

  • history or prostate cancer treatment (prostatectomy, radiation, brachytherapy)

Study Design

Total Participants: 13
Treatment Group(s): 2
Primary Treatment: Placebo Sham Injection
Phase: 3
Study Start date:
April 01, 2021
Estimated Completion Date:
November 02, 2022

Study Description

Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25).

Intervention and Evaluation:Men who consent to join the trial will be randomized to receive either a single injection PRP or saline to the penis. All patients will have blood drawn in clinic the day of injection. Those randomized to PRP arm will have their own blood prepared and separated into the PRP. This solution of their own blood will be injected back into the penis.

Follow Up: Men will be evaluated at 1 , 3, and 6 months after the injections and then asked to complete the IIEF by phone or by electronic means

Connect with a study center

  • Nebraska Medicine

    Omaha, Nebraska 68198
    United States

    Site Not Available

  • Unversity of Nebraska Medical Center

    Omaha, Nebraska 68198
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.